Self-renewal and scalability of human embryonic stem cells for human therapy

Regenerative Medicine

Volumn 6, Issue 3, 2011, Pages 327-334

  Fu, Xuemei ^a,b   Xu, Yang ^b  

^a CHENGDU WOMEN S AND CHILDREN S CENTRAL HOSPITAL   (China)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

apoptosis; genetic stability; human embryonic stem cells; pluripotency; scalability; self renewal

Indexed keywords

ACRYLIC ACID DERIVATIVE; BASIC FIBROBLAST GROWTH FACTOR; BONE MORPHOGENETIC PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LAMININ 10; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE; OCTAMER TRANSCRIPTION FACTOR 4; POLYMER; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR NANOG;

APOPTOSIS; CELL AGGREGATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL RENEWAL; CELL SCALABILITY; CELL SURVIVAL; CELL TYPE; CLINICAL STUDY; CULTURE MEDIUM; DNA DAMAGE; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENETIC CONSERVATION; GENOMIC INSTABILITY; GOOD LABORATORY PRACTICE; HUMAN; INTRACELLULAR SIGNALING; LARGE SCALE PRODUCTION; MATERIAL COATING; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA DEGENERATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SPINAL CORD INJURY; STEM CELL EXPANSION; STEM CELL TRANSPLANTATION; TISSUE CULTURE TECHNIQUE; TRANSCRIPTION REGULATION;

APOPTOSIS; CELL PROLIFERATION; EMBRYONIC STEM CELLS; GENE REGULATORY NETWORKS; GENOMIC INSTABILITY; HUMANS; PLURIPOTENT STEM CELLS; STEM CELL TRANSPLANTATION;

EID: 79955799022     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/rme.11.18     Document Type: Review

References (75)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al.: Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998). (Pubitemid 28516247)
2. Chambers I, Smith A: Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene 23(43), 7150-7160 (2004). (Pubitemid 39382149)
3. Humphrey RK, Beattie GM, Lopez AD et al.: Maintenance of pluripotency in human embryonic stem cells is STAT3 independent. Stem Cells 22(4), 522-530 (2004). (Pubitemid 39014568)
4. Chadwick K, Wang LS, Li L et al.: Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 102(3), 906-915 (2003). (Pubitemid 36917782)
5. Zhang PB, Li JA, Tan ZJ et al.: Short-term BMP-4 treatment initiates mesoderm induction in human embryonic stem cells. Blood 111(4), 1933-1941 (2008).
6. Nichols J, Smith A: The origin and identity of embryonic stem cells. Development 138(1), 3-8 (2010).
7. Eiselleova L, Matulka K, Kriz V et al.: A complex role for FGF-2 in self-renewal, survival, and adhesion of human embryonic stem cells. Stem Cells 27(8), 1847-1857 (2009).
8. Besser D: Expression of nodal, lefty-A, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3. J. Biol. Chem. 279(43), 45076-45084 (2004). (Pubitemid 39430922)
9. Vallier L, Alexander M, Pedersen RA: Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci. 118(19), 4495-4509 (2005). (Pubitemid 41556347)
10. Lee KW, Yook JY, Son MY et al.: Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway. Stem Cells Dev. 19(4), 557-568 (2010).
11. Jiaxi ZX, Su P, Wang L et al.: mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cells. Proc. Natl Acad. Sci. USA 106(19), 7840-7845 (2009).
12. Easley CA, Ben-Yehudah A, Redinger CJ et al.: mTOR-mediated activation of p70 S6K induces differentiation of pluripotent human embryonic stem cells. Cell. Reprogram. 12(3), 263-273 (2010).
13. Valdimarsdottir G, Mummery C: Functions of the TGF-b superfamily in human embryonic stem cells. APMIS 113(11-12), 773-789 (2005). (Pubitemid 43934220)
14. Na J, Andrews P: The balancing action between Activin A/TGF-b, FGF, Writ and BMP signalling instructs human embryonic stem cell fate decisions. Mech. Dev. 126, S207 (2009).
15. Chambers I, Colby D, Robertson M et al.: Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113(5), 643-655 (2003). (Pubitemid 36694189)
16. Mitsui K, Tokuzawa Y, Itoh H et al.: The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113(5), 631-642. (2003). (Pubitemid 36694188)
17. Zaehres H, Lensch MW, Daheron L, Stewart SA, Itskovitz-Eldor J, Daley GQ: High-efficiency RNA interference in human embryonic stem cells. Stem Cells 23(3), 299-305 (2005). (Pubitemid 40404448)
18. Boyer LA, Lee TI, Cole MF et al.: Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122(6), 947-956. (2005). (Pubitemid 41345211)
19. Nichols J, Zevnik B, Anastassiadis K et al.: Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95(3), 379-391 (1998). (Pubitemid 28507326)
20. Kuroda T, Tada M, Kubota H et al.: Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol. Cell. Biol. 25(6), 2475-2485 (2005). (Pubitemid 40354640)
21. Adachi K, Suemori H, Yasuda S, Nakatsuji N, Kawase E: Role of SOX2 in maintaining pluripotency of human embryonic stem cells. Genes Cells 15(5), 455-469 (2010).
22. Boiani M, Scholer HR: Regulatory networks in embryo-derived pluripotent stem cells. Nat. Rev. Mol. Cell Biol. 6(11), 872-884 (2005). (Pubitemid 41568736)
23. Zhang PL, Andrianakos R, Yang Y, Liu CM, Lu WG: Kruppel-like factor 4 (Klf4) prevents embryonic stem (ES) cell differentiation by regulating Nanog gene expression. J. Biol. Chem. 285(12), 9180-9189 (2010).
24. Chan KK, Zhang J, Chia NY et al.: KLF4 and PBX1 directly regulate NANOG expression in human embryonic stem cells. Stem Cells 27(9), 2114-2125 (2009).
25. Lim Cy, Tam Wl, Zhang J et al.: Sall4 regulates distinct transcription circuitries in different blastocyst-derived stem cell lineages. Cell Stem Cell 3(5), 543-554 (2008).
26. Wang ZX, Teh CHL, Chan CMY et al.: The Transcription factor Zfp281 controls embryonic stem cell pluripotency by direct activation and repression of target genes. Stem Cells 26(11), 2791-2799 (2008).
27. Chen X, Fang F, Liou YC, Ng HH: Zfp143 regulates Nanog through modulation of Oct4 binding. Stem Cells 26(11), 2759-2767 (2008).
28. Xu RH, Sampsell-Barron TL, Gu F et al.: NANOG is a direct target of TGF b/Activin-mediated SMAD signaling in human ESCs. Cell Stem Cell 3(2), 196-206 (2008).
29. Liang J, Wan M, Zhang Y et al.: Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat. Cell Biol. 10(6), 731-739 (2008). (Pubitemid 351772939)
30. Mallanna SK, Rizzino A: Emerging roles of microRNAs in the control of embryonic stem cells and the generation of induced pluripotent stem cells. Dev. Biol. 344(1), 16-25 (2010).
31. Fujita J, Crane AM, Souza MK et al.: Caspase activity mediates the differentiation of embryonic stem cells. Cell Stem Cell 2(6), 595-601 (2008). (Pubitemid 351729216)
32. Moretto-Zita M, Jin H, Shen ZX, Zhao TB, Briggs SP, Xu Y: Phosphorylation stabilizes Nanog by promoting its interaction with Pin1. Proc. Natl Acad. Sci. USA 107(30), 13312-13317 (2010).
33. Tsuruzoe S, Ishihara K, Uchimura Y et al.: Inhibition of DNA binding of Sox2 by the SUMO conjugation. Biochem. Biophys. Res. Commun. 351(4), 920-926 (2006). (Pubitemid 44715874)
34. Ohgushi M, Matsumura M, Eiraku M et al.: Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. Cell Stem Cell 7(2), 225-239 (2010).
35. Watanabe K, Ueno M, Kamiya D et al.: A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 25(6), 681-686 (2007). (Pubitemid 46897207)
36. Emre N, Vidal JG, Elia J et al.: The ROCK inhibitor Y-27632 improves recovery of human embryonic stem cells after fluorescence-activated cell sorting with multiple cell surface markers. PLoS One 5(8), e12148 (2010).
37. Baharvand H, Salekdeh GH, Taei A, Mollamohammadi S: An efficient and easy-to-use cryopreservation protocol for human ES and iPS cells. Nat. Protoc. 5(3), 588-594 (2010).
38. Song H, Chung S-K, Xu Y: Modeling disease in human ESCs using an efficient BAC-based homologous recombination system. Cell Stem Cell 6(1), 80-89 (2010).
39. Ferretti R, Palumbo V, Di Savino A et al.: Morgana/chp-1, a ROCK inhibitor involved in centrosome duplication and tumorigenesis. Dev. Cell 18(3), 486-495 (2010).
40. Baxter MA, Camarasa MV, Bates N et al.: Analysis of the distinct functions of growth factors and tissue culture substrates necessary for the long-term self-renewal of human embryonic stem cell lines. Stem Cell Res. 3(1), 28-38 (2009).
41. Xu Y, Zhu XW, Hahm HS et al.: Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules. Proc. Natl Acad. Sci. USA 107(18), 8129-8134 (2010).
42. Li D, Zhou JX, Wang L et al.: Integrated biochemical and mechanical signals regulate multifaceted human embryonic stem cell functions. J. Cell Biol. 191(3), 631-644 (2010).
43. Li L, Wang SA, Jezierski A et al.: A Unique interplay between Rap1 and E-cadherin in the endocytic pathway regulates self-renewal of human embryonic stem cells. Stem Cells 28(2), 247-257 (2010).
44. Miura T, Mattson MP, Rao MS: Cellular lifespan and senescence signaling in embryonic stem cells. Aging Cell 3(6), 333-343 (2004). (Pubitemid 40246703)
45. Kim SJ, Cheon SH, Yoo SJ et al.: Contribution of the PI3K/Akt/PKB signal pathway to maintenance of self-renewal in human embryonic stem cells. FEBS Lett. 579(2), 534-540 (2005). (Pubitemid 40092440)
46. Bendall SC, Stewart MH, Menendez P et al.: IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 448(7157), 1015-1021 (2007). (Pubitemid 47345578)
47. Mattson MP, Meffert MK: Roles for NF-kB in nerve cell survival, plasticity, and disease. Cell Death Differ. 13(5), 852-860 (2006).
48. Kang HB, Kim YE, Kwon HJ, Sok DE, Lee YH: Enhancement of NF-kB expression and activity upon differentiation of human embryonic stem cell line SNUhES3. Stem Cells Dev. 16(4), 615-623 (2007).
49. Yang CB, Atkinson SP, Vilella F et al.: Opposing putative roles for canonical and noncanonical NF-kB signaling on the survival, proliferation, and differentiation potential of human embryonic stem cells. Stem Cells 28(11), 1970-1980 (2010).
50. Cervantes RB, Stringer JR, Shao C, Tischfield JA, Stambrook PJ: Embryonic stem cells and somatic cells differ in mutation frequency and type. Proc. Natl Acad. Sci. USA 99(6), 3586-3590 (2002). (Pubitemid 34256391)
51. Narva E, Autio R, Rahkonen N et al.: High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat. Biotechnol. 28(4), 371-377 (2010).
52. Laurent LC, Ulitsky I, Slavin I et al.: Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8(1), 106-118 (2011).
53. Momcilovic O, Choi S, Varum S, Bakkenist C, Schatten G, Navara C: Ionizing radiation induces ataxia telangiectasia mutated-dependent checkpoint signaling and cell cycle arrest in pluripotent human embryonic stem cells. Stem Cells 27(8), 1822-1835 (2009).
54. Vousden KH, Prives C: Blinded by the light: the growing complexity of p53. Cell 137(3), 413-431 (2009).
55. Lin T, Chao C, Saito SI et al.: p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat. Cell Biol. 7(2), 165-171 (2005). (Pubitemid 40268131)
56. Liu DP, Ou LD, Clemenson GD et al.: Puma is required for p53-induced depletion of adult stem cells. Nat. Cell Biol. 12(10), 993-998 (2010).
57. Martin MJ, Muotri A, Gage F, Varki A: Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat. Med. 11(2), 228-232 (2005). (Pubitemid 40321360)
58. Crook JM, Peura TT, Kravets L et al.: The generation of six clinical-grade human embryonic stem cell lines. Cell Stem Cell 1(5), 490-494 (2007). (Pubitemid 350056410)
59. Sivarajah S, Raj GS, Mathews AJV, Sahib NBE, Hwang WS, Crook JM: The generation of GLP-grade human embryonic stem cell banks from four clinical-grade cell lines for preclinical research. In Vitro Cell. Dev. Biol. Anim. 46(3-4), 210-216 (2010).
60. Englund MCO, Caisander G, Noaksson K et al.: The establishment of 20 different human embryonic stem cell lines and subclones; a report on derivation, culture, characterisation and banking. In Vitro Cell. Dev. Biol. Anim. 46(3-4), 217-230 (2010).
61. Meng GL, Liu SY, Li XY, Krawetz R, Rancourt DE: Extracellular matrix isolated from foreskin fibroblasts supports long-term xeno-free human embryonic stem cell culture. Stem Cells Dev. 19(4), 547-556 (2010).
62. Aguilar-Gallardo C, Poo M, Gomez E et al.: Derivation, characterization, differentiation, and registration of seven human embryonic stem cell lines (VAL-3, -4, -5, -6M, -7, -8, and -9) on human feeder. In Vitro Cell. Dev. Biol. Anim. 46(3-4), 317-326 (2010).
63. Tecirlioglu RT, Nguyen L, Koh K, Trounson AO, Michalska AE: Derivation and maintenance of human embryonic stem cell line on human adult skin fibroblast feeder cells in serum replacement medium. In Vitro Cell. Dev. Biol. Anim. 46(3-4), 231-235 (2010).
64. Park Y, Choi IY, Lee SJ et al.: Undifferentiated propagation of the human embryonic stem cell lines, H1 and HSF6, on human placenta-derived feeder cells without basic fibroblast growth factor supplementation. Stem Cells Dev. 19(11), 1713-1722 (2010).
65. Rodin S, Domogatskaya A, Strom S et al.: Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat. Biotechnol. 28(6), 611-615 (2010).
66. Prowse ABJ, Doran MR, Cooper-White JJ et al.: Long term culture of human embryonic stem cells on recombinant vitronectin in ascorbate free media. Biomaterials 31(32), 8281-8288 (2010).
67. Ludwig TE, Bergendahl V, Levenstein ME, Yu J, Probasco MD, Thomson JA: Feeder-independent culture of human embryonic stem cells. Nat. Meth. 3(8), 637-646 (2006). (Pubitemid 44123431)
68. Wang L, Schulz TC, Sherrer ES et al.: Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Blood 110(12), 4111-4119 (2007). (Pubitemid 350248470)
69. Yao S, Chen S, Clark J et al.: Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc. Natl Acad. Sci. USA 103(18), 6907-6912 (2006).
70. Melkoumian Z, Weber JL, Weber DM et al.: Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat. Biotechnol. 28(6), 606-695 (2010).
71. Yoon BS, Jun EK, Park G et al.: Optimal suppression of protein phosphatase 2A activity is critical for maintenance of human embryonic stem cell self-renewal. Stem Cells 28(5), 874-884 (2010).
72. Wu DM, Pang YH, Ke YH et al.: A conserved mechanism for control of human and mouse embryonic stem cell pluripotency and differentiation by Shp2 tyrosine phosphatase. PLoS One 4(3), e4914 (2009).
73. Villa-Diaz LG, Nandivada H, Ding J et al.: Synthetic polymer coatings for long-term growth of human embryonic stem cells. Nat. Biotechnol. 28(6), 581-583 (2010).
74. Serra M, Brito C, Sousa MFQ et al.: Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control. J. Biotechnol. 148(4), 208-215 (2010).
75. Steiner D, Khaner H, Cohen M et al.: Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension. Nat. Biotechnol. 28(4), 361-364 (2010).